Phase I study of gemcitabine using a once every 2 weeks schedule.
about
Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.A rash diagnosis: Gemcitabine-associated pseudocellulitis.Gemcitabine in combination with paclitaxel for the treatment of metastatic breast cancer.Synergistic effect of sequential administration of mitoguazone (MGBG) and gemcitabine in treating tissue cultured human breast cancer cells and mammary rat tumors.A phase I human trial of mitoguazone and gemcitabine sequential bi-weekly treatment of cancer patients.
P2860
Phase I study of gemcitabine using a once every 2 weeks schedule.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Phase I study of gemcitabine using a once every 2 weeks schedule.
@ast
Phase I study of gemcitabine using a once every 2 weeks schedule.
@en
type
label
Phase I study of gemcitabine using a once every 2 weeks schedule.
@ast
Phase I study of gemcitabine using a once every 2 weeks schedule.
@en
prefLabel
Phase I study of gemcitabine using a once every 2 weeks schedule.
@ast
Phase I study of gemcitabine using a once every 2 weeks schedule.
@en
P2093
P2860
P356
P1476
Phase I study of gemcitabine using a once every 2 weeks schedule.
@en
P2093
C McDaniels
J B Vermorken
J P Guastalla
M D Clavel
P2860
P2888
P304
P356
10.1038/BJC.1997.583
P407
P577
1997-01-01T00:00:00Z